These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 11082977)
1. [The influence of hormone replacement therapy (HRT) on bone density in menopausal women in relation to vitamin D receptor (VDR) and estrogen receptor (ER)]. Brodowska A Ginekol Pol; 2000 Sep; 71(9):1071-4. PubMed ID: 11082977 [TBL] [Abstract][Full Text] [Related]
2. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes]. Brodowska A Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. Gennari L; Becherini L; Masi L; Mansani R; Gonnelli S; Cepollaro C; Martini S; Montagnani A; Lentini G; Becorpi AM; Brandi ML J Clin Endocrinol Metab; 1998 Mar; 83(3):939-44. PubMed ID: 9506753 [TBL] [Abstract][Full Text] [Related]
4. Genetic control of bone density and turnover: role of the collagen 1alpha1, estrogen receptor, and vitamin D receptor genes. Brown MA; Haughton MA; Grant SF; Gunnell AS; Henderson NK; Eisman JA J Bone Miner Res; 2001 Apr; 16(4):758-64. PubMed ID: 11316004 [TBL] [Abstract][Full Text] [Related]
5. The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes. Brodowska A; Starczewski A; Brodowski J; Szydłowska I; Nawrocka-Rutkowska J Gynecol Endocrinol; 2009 May; 25(5):315-23. PubMed ID: 19903038 [TBL] [Abstract][Full Text] [Related]
6. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes. Deng HW; Li J; Li JL; Johnson M; Gong G; Davis KM; Recker RR Hum Genet; 1998 Nov; 103(5):576-85. PubMed ID: 9860300 [TBL] [Abstract][Full Text] [Related]
7. Association of vitamin D and estrogen receptor gene polymorphism with the effects of longterm hormone replacement therapy on bone mineral density. Kurabayashi T; Matsushita H; Tomita M; Kato N; Kikuchi M; Nagata H; Honda A; Yahata T; Tanaka K J Bone Miner Metab; 2004; 22(3):241-7. PubMed ID: 15108066 [TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin D receptor and estrogen receptor gene polymorphism on the relationship between dietary calcium and bone mineral density in Japanese women. Kurabayashi T; Matsushita H; Kato N; Nagata H; Kikuchi M; Tomita M; Yahata T; Honda A; Tanaka K J Bone Miner Metab; 2004; 22(2):139-47. PubMed ID: 14999525 [TBL] [Abstract][Full Text] [Related]
9. [Association of bone mineral density with gene polymorphisms and environmental factors in Chinese postmenopausal women]. Dong J; Huang ZW; Piao JH; Gong J Wei Sheng Yan Jiu; 2006 Mar; 35(2):196-200. PubMed ID: 16758971 [TBL] [Abstract][Full Text] [Related]
10. [Study on the relationship between some genetic factors and peak bone mineral density in Beijing young women]. Yang X; Zheng SR; Chen RJ; Chen SL; Fan ZH; Li H; Lu YH Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):273-6. PubMed ID: 12895309 [TBL] [Abstract][Full Text] [Related]
11. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934 [TBL] [Abstract][Full Text] [Related]
12. [Polymorphism of vitamin D receptor Bsm I gene and of estrogen receptor Xba I and Pvu II gene in girls and women with low bone mass]. Sowińska-Przepiera E; Grys E Ginekol Pol; 2000 Aug; 71(8):673-9. PubMed ID: 11082900 [TBL] [Abstract][Full Text] [Related]
13. The association between heel ultrasound and hormone replacement therapy is modulated by a two-locus vitamin D and estrogen receptor genotype. Giguère Y; Dodin S; Blanchet C; Morgan K; Rousseau F J Bone Miner Res; 2000 Jun; 15(6):1076-84. PubMed ID: 10841176 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein receptor-related protein 5 and vitamin D receptor gene polymorphisms in relation to vitamin D levels in menopause. Zajickova K; Hill M; Vankova M; Zofkova I Clin Chem Lab Med; 2006; 44(9):1066-9. PubMed ID: 16958596 [TBL] [Abstract][Full Text] [Related]
15. [Association of bone mineral density with vitamin D receptor gene polymorphism--changes in radial bone mineral density with long-term follow-up: longitudinal study]. Murakami F; Hagino H; Shimomura T; Ikawa S; Hirano Y; Iijima K; Yamamoto K Rinsho Byori; 1998 Aug; 46(8):766-73. PubMed ID: 9760828 [TBL] [Abstract][Full Text] [Related]
16. Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. Macdonald HM; McGuigan FE; Stewart A; Black AJ; Fraser WD; Ralston S; Reid DM J Bone Miner Res; 2006 Jan; 21(1):151-62. PubMed ID: 16355284 [TBL] [Abstract][Full Text] [Related]
17. Osteoporosis: new hope for the future. Masi L; Bilezikian JP Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458 [TBL] [Abstract][Full Text] [Related]
18. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study. Ferrari SL; Karasik D; Liu J; Karamohamed S; Herbert AG; Cupples LA; Kiel DP J Bone Miner Res; 2004 Apr; 19(4):552-9. PubMed ID: 15005841 [TBL] [Abstract][Full Text] [Related]
19. The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH J Bone Miner Res; 2000 Dec; 15(12):2479-86. PubMed ID: 11127213 [TBL] [Abstract][Full Text] [Related]
20. Genetic markers, bone mineral density, and serum osteocalcin levels. Sowers M; Willing M; Burns T; Deschenes S; Hollis B; Crutchfield M; Jannausch M J Bone Miner Res; 1999 Aug; 14(8):1411-9. PubMed ID: 10457274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]